This report aims to provide a comprehensive study of the global market for OTC Antihistamine. Report Highlights:
(1) Global OTC Antihistamine market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global OTC Antihistamine market competitive situation, revenue and market share, from 2018 to 2022.
(3) China OTC Antihistamine market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global OTC Antihistamine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global OTC Antihistamine segment by type and by application and regional segment by type and by application.
(6) OTC Antihistamine industry supply chain, upstream, midstream and downstream analysis.
According to YH Research, the global market for OTC Antihistamine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China OTC Antihistamine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States OTC Antihistamine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Oral Solution segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of OTC Antihistamine include Merck, Pfizer, Bayer, Teva, Cadila Pharmaceuticals, PAI Pharma, Dr. Reddy's Laboratories, Johnson & Johnson and SANOFI, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Oral Solution
Tablet
Capsule
Market segment by application, can be divided into
Hospital
Clinic
Drug Store
Market segment by players, this report covers
Merck
Pfizer
Bayer
Teva
Cadila Pharmaceuticals
PAI Pharma
Dr. Reddy's Laboratories
Johnson & Johnson
SANOFI
PL Developments
APOTEX
Morepen
Ultratech India
Vasudha Pharma Chem
Hetero Drugs
Mylan
Changzhou Yabang
Shaanxi Hanjiang
Inke, S.A.
Argon Drugs
Covis Pharma
1 Market Overview
1.1 Product Overview and Scope of OTC Antihistamine
1.2 Global OTC Antihistamine Market Size and Forecast
1.3 China OTC Antihistamine Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China OTC Antihistamine Share in Global Market, 2018-2029
1.4.2 OTC Antihistamine Market Size: China VS Global, 2018-2029
1.5 OTC Antihistamine Market Dynamics
1.5.1 OTC Antihistamine Market Drivers
1.5.2 OTC Antihistamine Market Restraints
1.5.3 OTC Antihistamine Industry Trends
1.5.4 OTC Antihistamine Industry Policy
2 Global Competitive Situation by Company
2.1 Global OTC Antihistamine Revenue by Company (2018-2023)
2.2 Global OTC Antihistamine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global OTC Antihistamine Concentration Ratio
2.4 Global OTC Antihistamine Mergers & Acquisitions, Expansion Plans
2.5 Global OTC Antihistamine Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China OTC Antihistamine Revenue by Company (2018-2023)
3.2 China OTC Antihistamine OTC Antihistamine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China OTC Antihistamine, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 OTC Antihistamine Industry Chain
4.2 OTC Antihistamine Upstream Analysis
4.3 OTC Antihistamine Midstream Analysis
4.4 OTC Antihistamine Downstream Analysis
5 Sights by Type
5.1 OTC Antihistamine Classification
5.1.1 Oral Solution
5.1.2 Tablet
5.1.3 Capsule
5.2 By Type, Global OTC Antihistamine Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global OTC Antihistamine Revenue, 2018-2029
6 Sights by Application
6.1 OTC Antihistamine Segment by Application
6.1.1 Hospital
6.1.2 Clinic
6.1.3 Drug Store
6.2 By Application, Global OTC Antihistamine Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global OTC Antihistamine Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global OTC Antihistamine Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global OTC Antihistamine Market Size, 2018-2029
7.3 North America
7.3.1 North America OTC Antihistamine Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America OTC Antihistamine Market Size Market Share
7.4 Europe
7.4.1 Europe OTC Antihistamine Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe OTC Antihistamine Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific OTC Antihistamine Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific OTC Antihistamine Market Size Market Share
7.6 South America
7.6.1 South America OTC Antihistamine Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America OTC Antihistamine Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global OTC Antihistamine Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global OTC Antihistamine Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. OTC Antihistamine Market Size, 2018-2029
8.3.2 By Company, U.S. OTC Antihistamine Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe OTC Antihistamine Market Size, 2018-2029
8.4.2 By Company, Europe OTC Antihistamine Revenue Market Share, 2018-2023
8.4.3 By Type, Europe OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China OTC Antihistamine Market Size, 2018-2029
8.5.2 By Company, China OTC Antihistamine Revenue Market Share, 2018-2023
8.5.3 By Type, China OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan OTC Antihistamine Market Size, 2018-2029
8.6.2 By Company, Japan OTC Antihistamine Revenue Market Share, 2018-2023
8.6.3 By Type, Japan OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea OTC Antihistamine Market Size, 2018-2029
8.7.2 By Company, South Korea OTC Antihistamine Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia OTC Antihistamine Market Size, 2018-2029
8.8.2 By Company, Southeast Asia OTC Antihistamine Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India OTC Antihistamine Market Size, 2018-2029
8.9.2 By Company, India OTC Antihistamine Revenue Market Share, 2018-2023
8.9.3 By Type, India OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia OTC Antihistamine Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia OTC Antihistamine Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia OTC Antihistamine Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia OTC Antihistamine Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Merck
9.1.1 Merck Company Information, Head Office, Market Area and Industry Position
9.1.2 Merck Company Profile and Main Business
9.1.3 Merck OTC Antihistamine Models, Specifications and Application
9.1.4 Merck OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.1.5 Merck Recent Developments
9.2 Pfizer
9.2.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.2.2 Pfizer Company Profile and Main Business
9.2.3 Pfizer OTC Antihistamine Models, Specifications and Application
9.2.4 Pfizer OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.2.5 Pfizer Recent Developments
9.3 Bayer
9.3.1 Bayer Company Information, Head Office, Market Area and Industry Position
9.3.2 Bayer Company Profile and Main Business
9.3.3 Bayer OTC Antihistamine Models, Specifications and Application
9.3.4 Bayer OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.3.5 Bayer Recent Developments
9.4 Teva
9.4.1 Teva Company Information, Head Office, Market Area and Industry Position
9.4.2 Teva Company Profile and Main Business
9.4.3 Teva OTC Antihistamine Models, Specifications and Application
9.4.4 Teva OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.4.5 Teva Recent Developments
9.5 Cadila Pharmaceuticals
9.5.1 Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.5.2 Cadila Pharmaceuticals Company Profile and Main Business
9.5.3 Cadila Pharmaceuticals OTC Antihistamine Models, Specifications and Application
9.5.4 Cadila Pharmaceuticals OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.5.5 Cadila Pharmaceuticals Recent Developments
9.6 PAI Pharma
9.6.1 PAI Pharma Company Information, Head Office, Market Area and Industry Position
9.6.2 PAI Pharma Company Profile and Main Business
9.6.3 PAI Pharma OTC Antihistamine Models, Specifications and Application
9.6.4 PAI Pharma OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.6.5 PAI Pharma Recent Developments
9.7 Dr. Reddy's Laboratories
9.7.1 Dr. Reddy's Laboratories Company Information, Head Office, Market Area and Industry Position
9.7.2 Dr. Reddy's Laboratories Company Profile and Main Business
9.7.3 Dr. Reddy's Laboratories OTC Antihistamine Models, Specifications and Application
9.7.4 Dr. Reddy's Laboratories OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.7.5 Dr. Reddy's Laboratories Recent Developments
9.8 Johnson & Johnson
9.8.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.8.2 Johnson & Johnson Company Profile and Main Business
9.8.3 Johnson & Johnson OTC Antihistamine Models, Specifications and Application
9.8.4 Johnson & Johnson OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.8.5 Johnson & Johnson Recent Developments
9.9 SANOFI
9.9.1 SANOFI Company Information, Head Office, Market Area and Industry Position
9.9.2 SANOFI Company Profile and Main Business
9.9.3 SANOFI OTC Antihistamine Models, Specifications and Application
9.9.4 SANOFI OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.9.5 SANOFI Recent Developments
9.10 PL Developments
9.10.1 PL Developments Company Information, Head Office, Market Area and Industry Position
9.10.2 PL Developments Company Profile and Main Business
9.10.3 PL Developments OTC Antihistamine Models, Specifications and Application
9.10.4 PL Developments OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.10.5 PL Developments Recent Developments
9.11 APOTEX
9.11.1 APOTEX Company Information, Head Office, Market Area and Industry Position
9.11.2 APOTEX Company Profile and Main Business
9.11.3 APOTEX OTC Antihistamine Models, Specifications and Application
9.11.4 APOTEX OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.11.5 APOTEX Recent Developments
9.12 Morepen
9.12.1 Morepen Company Information, Head Office, Market Area and Industry Position
9.12.2 Morepen Company Profile and Main Business
9.12.3 Morepen OTC Antihistamine Models, Specifications and Application
9.12.4 Morepen OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.12.5 Morepen Recent Developments
9.13 Ultratech India
9.13.1 Ultratech India Company Information, Head Office, Market Area and Industry Position
9.13.2 Ultratech India Company Profile and Main Business
9.13.3 Ultratech India OTC Antihistamine Models, Specifications and Application
9.13.4 Ultratech India OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.13.5 Ultratech India Recent Developments
9.14 Vasudha Pharma Chem
9.14.1 Vasudha Pharma Chem Company Information, Head Office, Market Area and Industry Position
9.14.2 Vasudha Pharma Chem Company Profile and Main Business
9.14.3 Vasudha Pharma Chem OTC Antihistamine Models, Specifications and Application
9.14.4 Vasudha Pharma Chem OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.14.5 Vasudha Pharma Chem Recent Developments
9.15 Hetero Drugs
9.15.1 Hetero Drugs Company Information, Head Office, Market Area and Industry Position
9.15.2 Hetero Drugs Company Profile and Main Business
9.15.3 Hetero Drugs OTC Antihistamine Models, Specifications and Application
9.15.4 Hetero Drugs OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.15.5 Hetero Drugs Recent Developments
9.16 Mylan
9.16.1 Mylan Company Information, Head Office, Market Area and Industry Position
9.16.2 Mylan Company Profile and Main Business
9.16.3 Mylan OTC Antihistamine Models, Specifications and Application
9.16.4 Mylan OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.16.5 Mylan Recent Developments
9.17 Changzhou Yabang
9.17.1 Changzhou Yabang Company Information, Head Office, Market Area and Industry Position
9.17.2 Changzhou Yabang Company Profile and Main Business
9.17.3 Changzhou Yabang OTC Antihistamine Models, Specifications and Application
9.17.4 Changzhou Yabang OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.17.5 Changzhou Yabang Recent Developments
9.18 Shaanxi Hanjiang
9.18.1 Shaanxi Hanjiang Company Information, Head Office, Market Area and Industry Position
9.18.2 Shaanxi Hanjiang Company Profile and Main Business
9.18.3 Shaanxi Hanjiang OTC Antihistamine Models, Specifications and Application
9.18.4 Shaanxi Hanjiang OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.18.5 Shaanxi Hanjiang Recent Developments
9.19 Inke, S.A.
9.19.1 Inke, S.A. Company Information, Head Office, Market Area and Industry Position
9.19.2 Inke, S.A. Company Profile and Main Business
9.19.3 Inke, S.A. OTC Antihistamine Models, Specifications and Application
9.19.4 Inke, S.A. OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.19.5 Inke, S.A. Recent Developments
9.20 Argon Drugs
9.20.1 Argon Drugs Company Information, Head Office, Market Area and Industry Position
9.20.2 Argon Drugs Company Profile and Main Business
9.20.3 Argon Drugs OTC Antihistamine Models, Specifications and Application
9.20.4 Argon Drugs OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.20.5 Argon Drugs Recent Developments
9.21 Covis Pharma
9.21.1 Covis Pharma Company Information, Head Office, Market Area and Industry Position
9.21.2 Covis Pharma Company Profile and Main Business
9.21.3 Covis Pharma OTC Antihistamine Models, Specifications and Application
9.21.4 Covis Pharma OTC Antihistamine Revenue and Gross Margin, 2018-2023
9.21.5 Covis Pharma Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. OTC Antihistamine Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. OTC Antihistamine Market Restraints
Table 3. OTC Antihistamine Market Trends
Table 4. OTC Antihistamine Industry Policy
Table 5. Global OTC Antihistamine Revenue by Company (2018-2023) & (US$ million)
Table 6. Global OTC Antihistamine Revenue Market Share by Company (2018-2023)
Table 7. Global OTC Antihistamine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global OTC Antihistamine Mergers & Acquisitions, Expansion Plans
Table 9. Global OTC Antihistamine Manufacturers Product Type
Table 10. China OTC Antihistamine Revenue by Company (2018-2023) & (US$ million)
Table 11. China OTC Antihistamine Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of OTC Antihistamine Upstream (Raw Materials)
Table 13. Global OTC Antihistamine Typical Customers
Table 14. OTC Antihistamine Typical Distributors
Table 15. By Type, Global OTC Antihistamine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global OTC Antihistamine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global OTC Antihistamine Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global OTC Antihistamine Revenue, 2018-2029, US$ Million
Table 19. By Country, Global OTC Antihistamine Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global OTC Antihistamine Revenue, 2018-2029, US$ Million
Table 21. By Country, Global OTC Antihistamine Revenue Market Share, 2018-2029
Table 22. Merck Company Information, Head Office, Market Area and Industry Position
Table 23. Merck Company Profile and Main Business
Table 24. Merck OTC Antihistamine Models, Specifications and Application
Table 25. Merck OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 26. Merck Recent Developments
Table 27. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 28. Pfizer Company Profile and Main Business
Table 29. Pfizer OTC Antihistamine Models, Specifications and Application
Table 30. Pfizer OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 31. Pfizer Recent Developments
Table 32. Bayer Company Information, Head Office, Market Area and Industry Position
Table 33. Bayer Company Profile and Main Business
Table 34. Bayer OTC Antihistamine Models, Specifications and Application
Table 35. Bayer OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 36. Bayer Recent Developments
Table 37. Teva Company Information, Head Office, Market Area and Industry Position
Table 38. Teva Company Profile and Main Business
Table 39. Teva OTC Antihistamine Models, Specifications and Application
Table 40. Teva OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 41. Teva Recent Developments
Table 42. Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 43. Cadila Pharmaceuticals Company Profile and Main Business
Table 44. Cadila Pharmaceuticals OTC Antihistamine Models, Specifications and Application
Table 45. Cadila Pharmaceuticals OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 46. Cadila Pharmaceuticals Recent Developments
Table 47. PAI Pharma Company Information, Head Office, Market Area and Industry Position
Table 48. PAI Pharma Company Profile and Main Business
Table 49. PAI Pharma OTC Antihistamine Models, Specifications and Application
Table 50. PAI Pharma OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 51. PAI Pharma Recent Developments
Table 52. Dr. Reddy's Laboratories Company Information, Head Office, Market Area and Industry Position
Table 53. Dr. Reddy's Laboratories Company Profile and Main Business
Table 54. Dr. Reddy's Laboratories OTC Antihistamine Models, Specifications and Application
Table 55. Dr. Reddy's Laboratories OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 56. Dr. Reddy's Laboratories Recent Developments
Table 57. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 58. Johnson & Johnson Company Profile and Main Business
Table 59. Johnson & Johnson OTC Antihistamine Models, Specifications and Application
Table 60. Johnson & Johnson OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 61. Johnson & Johnson Recent Developments
Table 62. SANOFI Company Information, Head Office, Market Area and Industry Position
Table 63. SANOFI Company Profile and Main Business
Table 64. SANOFI OTC Antihistamine Models, Specifications and Application
Table 65. SANOFI OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 66. SANOFI Recent Developments
Table 67. PL Developments Company Information, Head Office, Market Area and Industry Position
Table 68. PL Developments Company Profile and Main Business
Table 69. PL Developments OTC Antihistamine Models, Specifications and Application
Table 70. PL Developments OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 71. PL Developments Recent Developments
Table 72. APOTEX Company Information, Head Office, Market Area and Industry Position
Table 73. APOTEX Company Profile and Main Business
Table 74. APOTEX OTC Antihistamine Models, Specifications and Application
Table 75. APOTEX OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 76. APOTEX Recent Developments
Table 77. Morepen Company Information, Head Office, Market Area and Industry Position
Table 78. Morepen Company Profile and Main Business
Table 79. Morepen OTC Antihistamine Models, Specifications and Application
Table 80. Morepen OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 81. Morepen Recent Developments
Table 82. Ultratech India Company Information, Head Office, Market Area and Industry Position
Table 83. Ultratech India Company Profile and Main Business
Table 84. Ultratech India OTC Antihistamine Models, Specifications and Application
Table 85. Ultratech India OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 86. Ultratech India Recent Developments
Table 87. Vasudha Pharma Chem Company Information, Head Office, Market Area and Industry Position
Table 88. Vasudha Pharma Chem Company Profile and Main Business
Table 89. Vasudha Pharma Chem OTC Antihistamine Models, Specifications and Application
Table 90. Vasudha Pharma Chem OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 91. Vasudha Pharma Chem Recent Developments
Table 92. Hetero Drugs Company Information, Head Office, Market Area and Industry Position
Table 93. Hetero Drugs Company Profile and Main Business
Table 94. Hetero Drugs OTC Antihistamine Models, Specifications and Application
Table 95. Hetero Drugs OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 96. Hetero Drugs Recent Developments
Table 97. Mylan Company Information, Head Office, Market Area and Industry Position
Table 98. Mylan Company Profile and Main Business
Table 99. Mylan OTC Antihistamine Models, Specifications and Application
Table 100. Mylan OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 101. Mylan Recent Developments
Table 102. Changzhou Yabang Company Information, Head Office, Market Area and Industry Position
Table 103. Changzhou Yabang Company Profile and Main Business
Table 104. Changzhou Yabang OTC Antihistamine Models, Specifications and Application
Table 105. Changzhou Yabang OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 106. Changzhou Yabang Recent Developments
Table 107. Shaanxi Hanjiang Company Information, Head Office, Market Area and Industry Position
Table 108. Shaanxi Hanjiang Company Profile and Main Business
Table 109. Shaanxi Hanjiang OTC Antihistamine Models, Specifications and Application
Table 110. Shaanxi Hanjiang OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 111. Shaanxi Hanjiang Recent Developments
Table 112. Inke, S.A. Company Information, Head Office, Market Area and Industry Position
Table 113. Inke, S.A. Company Profile and Main Business
Table 114. Inke, S.A. OTC Antihistamine Models, Specifications and Application
Table 115. Inke, S.A. OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 116. Inke, S.A. Recent Developments
Table 117. Argon Drugs Company Information, Head Office, Market Area and Industry Position
Table 118. Argon Drugs Company Profile and Main Business
Table 119. Argon Drugs OTC Antihistamine Models, Specifications and Application
Table 120. Argon Drugs OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 121. Argon Drugs Recent Developments
Table 122. Covis Pharma Company Information, Head Office, Market Area and Industry Position
Table 123. Covis Pharma Company Profile and Main Business
Table 124. Covis Pharma OTC Antihistamine Models, Specifications and Application
Table 125. Covis Pharma OTC Antihistamine Revenue and Gross Margin, 2018-2023
Table 126. Covis Pharma Recent Developments
List of Figure
Figure 1. OTC Antihistamine Picture
Figure 2. Global OTC Antihistamine Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China OTC Antihistamine Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China OTC Antihistamine Market Share of Global
Figure 5. Global OTC Antihistamine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global OTC Antihistamine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China OTC Antihistamine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China OTC Antihistamine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. OTC Antihistamine Industry Chain
Figure 10. Oral Solution
Figure 11. Tablet
Figure 12. Capsule
Figure 13. By Type, Global OTC Antihistamine Revenue, 2018-2029, US$ Million
Figure 14. By Type, Global OTC Antihistamine Revenue Market Share, 2018-2029
Figure 15. Hospital
Figure 16. Clinic
Figure 17. Drug Store
Figure 18. By Application, Global OTC Antihistamine Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global OTC Antihistamine Revenue Market Share, 2018-2029
Figure 20. By Region, Global OTC Antihistamine Revenue Market Share, 2018-2029
Figure 21. North America OTC Antihistamine Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America OTC Antihistamine Revenue Market Share, 2018-2023
Figure 23. Europe OTC Antihistamine Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe OTC Antihistamine Revenue Market Share, 2018-2023
Figure 25. Asia Pacific OTC Antihistamine Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific OTC Antihistamine Revenue Market Share, 2018-2023
Figure 27. South America OTC Antihistamine Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America OTC Antihistamine Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa OTC Antihistamine Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. OTC Antihistamine Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. OTC Antihistamine Market Share, 2018-2023
Figure 32. By Type, U.S. OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 34. Europe OTC Antihistamine Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe OTC Antihistamine Market Share, 2018-2023
Figure 36. By Type, Europe OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 38. China OTC Antihistamine Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China OTC Antihistamine Market Share, 2018-2023
Figure 40. By Type, China OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 42. Japan OTC Antihistamine Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan OTC Antihistamine Market Share, 2018-2023
Figure 44. By Type, Japan OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 46. South Korea OTC Antihistamine Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea OTC Antihistamine Market Share, 2018-2023
Figure 48. By Type, South Korea OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia OTC Antihistamine Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia OTC Antihistamine Market Share, 2018-2023
Figure 52. By Type, Southeast Asia OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 54. India OTC Antihistamine Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India OTC Antihistamine Market Share, 2018-2023
Figure 56. By Type, India OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia OTC Antihistamine Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia OTC Antihistamine Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia OTC Antihistamine Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Reason to Buy